Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Boston Scientific puts up $600m for Augmenix

Boston Scientific puts up $600m for Augmenix

By

Boston Scientific acquires AugmenixBoston Scientific (NYSE:BSX) said yesterday that it put $600 million on the table for Augmenix and its SpaceOar device.

The deal for Bedford, Mass.-based Augmenix calls for $500 million in up-front cash and another $100 million pegged to sales-based milestones, Boston said. The SpaceOar hydrogel device, which won CE Mark approval in the European Union in 2010 and 510(k) clearance from the FDA in April 2015 , is designed to separate the prostate from the rectal wall during radiation treatment for prostate cancer. The product is delivered through a small needle as a liquid, which then solidifies into a soft gel that expands the space between the prostate and rectum during radiotherapy. After about three months, the substance begins to liquefy and is absorbed and cleared from the body in the patient’s urine within about six months.

Marlborough, Mass.-based Boston Scientific said SpaceOar sales could hit $50 million this year and near the $90 million mark next year. The deal is slated to close early in the fourth quarter, the company said.

“The acquisition furthers our category leadership strategy in urology and the SpaceOar hydrogel is a crucial addition to our growing prostate health treatment portfolio of products that improve the quality of life and clinical outcomes for men with prostate cancer and benign prostatic hyperplasia,” medsurg president Dave Pierce said in prepared remarks. “The injection of this hydrogel during a minimally-invasive, in-office procedure can reduce the unwanted and unintended side effects of prostate radiation and provide substantial peace of mind for patients and their treating physicians.”

“We are proud of the clinical and commercial outcomes we’ve been able to achieve for SpaceOAR hydrogel thus far, and are excited to drive accelerated adoption leveraging Boston Scientific’s urology and pelvic health expertise,” added Augmenix CEO John Pedersen. “The company also has the additional resources needed to further explore expansion of indication to other organs throughout the body that could benefit from space creation – such as gynecological and pancreatic cancers.”

Boston said it expects the Augmenix to begin adding to its adjusted earnings per share in 2020.

In case you missed it

RSS From Medical Design & Outsourcing

  • World’s largest contract chlorine dioxide sterilization chamber opens soon
    Boulder iQ division Boulder Sterilization will open what it said is the world’s largest contract chlorine dioxide (CD) sterilization chamber this summer. The 270-ft² chamber has capacity for two pallets at a time, allowing for batches and products of almost any size, the company said. Boulder, Colorado-based Boulder iQ said the new equipment will make… […]
  • Design firm Delve makes first acquisition under new owner
    Delve announced its acquisition of Boston-based digital innovation and design firm Altr this week. Madison, Wisconsin–based Delve said Altr is its first acquisition under the ownership of private equity firm Trinity Hunt Partners, which purchased Delve in May 2021 and merged it with product design consultancy firm Bresslergroup. “Almost two years ago to the day,… […]
  • 5 critical questions medical device manufacturers must ask potential lab testing partners
    You can learn a lot about a potential medical device testing partner by asking about experience, capacity, testing approaches, communication and pre-submission meetings. By Sandi Schaible, WuXi AppTec Medical Device Testing Selecting a laboratory testing partner can be tricky — it goes well beyond mere technical capabilities. Knowing the right questions to ask when choosing… […]
  • Okay Industries promotes to fill laser technologies manager role
    NEWS RELEASE: Okay Industries promotes Redi Nasto Okay Industries, a contract manufacturer of components and subassemblies for global original equipment manufacturers in the medical device markets, is pleased to announce the promotion of Redi Nasto to laser technologies manager. In his new role, Nasto will lead and manage all aspects of laser technologies and processes,… […]
  • 80-cent device prototype uses smartphone to monitor blood pressure
    University of California San Diego engineers have prototyped an inexpensive device that clips onto a smartphone to monitor a user’s blood pressure. The 3D-printed device uses the smartphone’s camera and flash paired with an algorithm on an app to take systolic and diastolic blood pressure readings. “We’ve created an inexpensive solution to lower the barrier… […]
  • The rundown on dip manufacturing for medical devices
    Dip molding and dip coating each have advantages and drawbacks for medical device manufacturing. By Dan Sanchez, Trelleborg Healthcare & Medical Dip molding and coating involve immersing an object into liquid silicone and either forming or coating a component. These methods can contribute to the success of a medical device project when correctly specified for… […]
  • Going Beyond In The Medical Devices Industry: Advanced Materials With USP Class VI Certification
    By Ronelle Decker, Senior Business Development Manager – Omniseal Solutions™ Life Science High Performance Life Science Material Options & Solutions Omniseal Solutions™ is a leading global engineering company specializing in the design and manufacture of precision sealing and material solutions for critical applications in challenging environments. For over 65 years, they have provided life science… […]
  • They said it at DeviceTalks Boston 2023
    Medical device industry leaders from Boston Scientific, Becton Dickinson, ZimVie, Medtronic, Stryker and more met at DeviceTalks Boston to share lessons learned and their perspectives on industry trends, device design and medtech innovation. Bidding farewell to DeviceTalks Boston 2023, we look back at an exceptional two-day medical device conference teeming with insights from over 100… […]
  • How LivaNova developed a next-generation perfusion system
    Access to technology, integrated systems and data reign supreme in the new era of perfusion. By Marco Dolci, LivaNova  Perfusionists are essential players on a cardiac surgery team, ensuring patients receive critical clinical support to maintain vital functions during a procedure. In short, the breath and heartbeat of patients’ lives rest in the hands of… […]
  • Brain-spine ‘digital bridge’ allows spinal cord injury patient to walk — and enjoy a beer
    A wireless “digital bridge” between a paralyzed patient’s brain and spinal cord has allowed him to walk naturally, researchers say. The experimental technology uses electronic implants on the brain and spinal cord to relay leg movement control signals, allowing 40-year-old Gert-Jan Oksam to walk again 12 years after a bicycle accident. Neuroscientists and neurosurgeons from… […]
  • AI breakthroughs in medtech: 7 ways to enhance healthcare
    Whether it’s OpenAI’s ChatGPT or Microsoft’s new Bing, 2023 is the year when generative artificial intelligence entered the popular consciousness. In the medtech space, it seems as though every company is seeking ways to incorporate some form of AI into the digital features of their products and services. So what is artificial intelligence good at… […]

Copyright © 2023 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy